Pharmacological characterization of a new, orally active and potent allosteric mGluR1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)

Data Supplement

Files in this Data Supplement:

• Data Supplement - This supplement contains:
  Supplemental Fig. 1. Effect of FTIDC on basal and agonist-induced increases in ...
  Supplemental Fig. 2. Chemical structures of FTIDC and other mGluR1 antagonists...
  Supplemental Fig. 3. In vivo antagonistic activity of YM-298198 on DHPG-induced face washing behavior...